Blunted nocturnal blood pressure decrease and left-ventricular mass in hypertensive hemodialysis patients

Riccardo M Fagugli1, Giuseppe Quintaliani, Paolo Pasini

  • 1Nephrology-Dialysis, Silvestrini Hospital, Perugia, Italy. rmfag@tin.it

Nephron
|May 22, 2002
PubMed

Insights

In hypertensive hemodialysis patients, most are non-dippers, but this classification doesn't significantly impact blood pressure or left ventricular mass. Volume overload is the primary driver of left ventricular hypertrophy in this population.

Area of Science:

  • Nephrology
  • Cardiology
  • Hypertension Research

Background:

  • Left-ventricular hypertrophy (LVH) is a common complication in hemodialysis (HD) patients.
  • Hypertension is a major risk factor for cardiac morbidity in HD patients, with many exhibiting a blunted nocturnal blood pressure (BP) decrease (non-dippers).
  • Previous studies in essential hypertensives suggest non-dippers have higher cardiac events and left ventricle (LV) mass, but results are conflicting in dialysis patients.

Purpose of the Study:

  • To investigate differences in LV mass between dipper and non-dipper hypertensive HD patients.
  • To assess the relationship between BP patterns, LV mass, and extracellular water distribution in HD patients.

Main Methods:

  • 24-hour ambulatory BP monitoring was conducted on HD and inter-HD days for 66 hypertensive HD patients.
  • Patients were classified as dippers (≥10% nocturnal systolic BP decrease) or non-dippers.
  • Echocardiography and bioimpedance were used to assess LV mass index (LVMi) and extracellular water (ECW) distribution.

Main Results:

  • 71% of patients were classified as non-dippers.
  • No significant differences in 48-hour systolic and diastolic BP or LVMi were observed between dipper and non-dipper groups.
  • A strong correlation was found between ECW percentage and LVMi (r = 0.53, p < 0.001), while BP parameters did not correlate with LVMi.

Conclusions:

  • The non-dipper status in hypertensive HD patients is not associated with significantly different 48-hour BP or LV mass compared to dippers.
  • Volume overload, indicated by ECW, appears to be the primary independent determinant of LVH in this patient cohort.
  • Clinical management should focus on volume status to address LVH in hypertensive HD patients.

Related Concept Videos

Hemodialysis III: Nursing Management01:25

Hemodialysis III: Nursing Management

The nursing management of a patient undergoing hemodialysis includes several critical steps, starting with a thorough assessment before the procedure.Before the Hemodialysis ProcedureFirst, record the patient's vital signs—blood pressure, heart rate, respiratory rate, and temperature—to establish a baseline. This baseline is essential for detecting conditions such as hypotension that could impact the patient's response to dialysis. Document the patient's pre-dialysis weight, as this measurement...
Hemodialysis II: Procedure and Complications01:24

Hemodialysis II: Procedure and Complications

DialyzersA hemodialysis (HD) dialyzer is a plastic cartridge containing thousands of parallel hollow fibers, which serve as semipermeable membranes. These fibers are typically made from cellulose-based or other synthetic materials. During HD, blood is pumped into the top of the cartridge and distributed among these fibers. Simultaneously, dialysis fluid, known as dialysate, is introduced into the bottom of the cartridge, bathing the outside of the fibers. Across the semipermeable membrane,...
Hypertension III: Clinical Manifestations and Diagnostic Studies01:30

Hypertension III: Clinical Manifestations and Diagnostic Studies

Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
Antihypertensive Drugs: Action of Diuretics01:16

Antihypertensive Drugs: Action of Diuretics

Diuretics are antihypertensive drugs used to treat hypertension resulting from sodium and water retention. Sodium, vital for fluid balance and nerve or muscle function, is regulated by the kidneys through millions of nephrons. Blood enters nephrons via afferent arterioles, which branch into capillaries called glomeruli. These filter blood plasma, allowing water and solutes, like sodium ions, to pass through capillary walls into Bowman's capsule. The filtrate then flows through various tubules...
Hypertension and Regulation of Blood Pressure01:18

Hypertension and Regulation of Blood Pressure

Hypertension, the most common cardiovascular disease, is diagnosed through repeated measurements of elevated blood pressure. Its risks, including damage to the kidney, heart, and brain, are directly proportional to blood pressure levels. Starting from 115/75 mm Hg, the risk of cardiovascular disease doubles with each increment of 20/10 mm Hg. The diagnosis relies on blood pressure measurements, not on patient symptoms, as hypertension is often asymptomatic until end-organ damage is imminent or...
Hypertension II: Pathophysiology01:29

Hypertension II: Pathophysiology

Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...